Drug Approval | September 24, 2025
Zydus receives EIR for oncology injectable manufacturing facility in Ahmedabad SEZ1
The facility has been classified as Voluntary Action Indicated
The facility has been classified as Voluntary Action Indicated
The inspection concluded with NIL observations
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
Eugia Pharma Specialities restarts production at terminally sterilized product lines
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection
The company will address the observations within a stipulated timeline working with the regulators
_256_384.jpg)
As of June 30, 2021, 267 out of a total of 427 SEZs approved by the government are operational
Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ
Prucalopride is prescribed for chronic idiopathic constipation
Subscribe To Our Newsletter & Stay Updated
